A $13 million seed investment was raised by AISAP, a Tel Aviv, Israel-based startup that offers an AI-powered point of care assisted diagnostic TM solution to the medical ultrasonography sector.
Leading the round were Shoni Top Ventures, L.P. and Harel Insurance Investments & Financial Services Ltd. The money will be used by the business to increase operations and development initiatives.
Read also – Israel-Based Travel-Tech company Travelier Acquires DeÔnibus
AISAP, which was founded by Adiel Am-Shalom, Ehud Raanani, Robert Klempfner, and Ehud Schwammenthal, is headed by CEO Roni Attali.
The company offers a POCADTM solution that incorporates AI-powered diagnoses, such as a “urgency score” that allows medical providers to prioritise cases based on the severity of the condition, a score that evaluates the quality of the scan for operators, ensuring accuracy even in situations where they are less experienced with traditional ultrasound devices, and Dee In the cardiovascular systems, the solution can even detect individual valves.
Read also – Israel-Based game developer Liberty Pixel Secures $1 Million in Pre-Seed Funding
More than 300,000 studies with over 24 million video clips were used to train AISAP’s algorithms, and a number of medical professionals from The Mayo Clinic, Inova Health Foundation, Jefferson Health, Poriya Institute, and other institutions have verified the technology.
About AISAP
AISAP helps clinicians employing Point-of-Care ultrasound to achieve excellent clinical outcomes and efficient healthcare delivery.
